Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

McKesson Said to Offer Celesio Bid of 23.50 Euros a Share

McKesson Corp. offered to raise its bid for German drug distributor Celesio AG to win support from U.S. hedge fund Elliott Management Corp., according to two people with knowledge of the matter.

McKesson would be prepared to pay 23.50 euros a share, up from 23 euros previously, said the people, who asked not to be identified because the discussions are confidential. The San Francisco-based company’s 3.9 billion-euro ($5.3 billion) tender offer, announced Oct. 24, expires at midnight Frankfurt time tonight.

The bid is conditional on support from stockholders representing 75 percent of Stuttgart, Germany-based Celesio’s stock. Elliott, the fund run by Paul Singer, has said the original 23-euro-a-share deal undervalues Celesio and the firm won’t tender its shares. Elliott holds more than 25 percent of the voting rights in Celesio.

Spokesmen for Celesio and Elliott declined to comment. Reuters reported the higher offer earlier today.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.